title: [33-year-old patient with postpartum myocardial infarct].
authors.affiliation: Klinik III für Innere Medizin, Universität zu Köln.
authors.forename: S
authors.initials: S
authors.lastname: Rosenkranz
authors.forename: H J
authors.initials: HJ
authors.lastname: Deutsch
authors.forename: E
authors.initials: E
authors.lastname: Erdmann
mesh_terms: D000328:Adult; D000632:Aminopyrine / Q000009:adverse effects* / Q000627:therapeutic use; D002110:Caffeine; D017023:Coronary Angiography / Q000187:drug effects; D003328:Coronary Thrombosis / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D003329:Coronary Vasospasm / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy; D004338:Drug Combinations; D004562:Electrocardiography / Q000187:drug effects; D004878:Ergotamine / Q000009:adverse effects* / Q000627:therapeutic use; D004881:Ergotism / Q000175:diagnosis*; D005260:Female; D005998:Glycine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D011437:Propylamines / Q000009:adverse effects* / Q000627:therapeutic use; D011644:Puerperal Disorders / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D047069:Pyrazolones; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
chemical_list: D004338:Drug Combinations; D011437:Propylamines; D047069:Pyrazolones; C002926:caffeine, camylofin, ergotamine, mecloxamine, propyphenazone drug combination; D000632:Aminopyrine; D002110:Caffeine; D010959:Tissue Plasminogen Activator; D004878:Ergotamine; D005998:Glycine